Literature DB >> 24577963

Perspective on the 2013 American Heart Association/American College of Cardiology guideline for the use of statins in primary prevention of low-risk individuals.

Jan L Breslow1.   

Abstract

Entities:  

Keywords:  cholesterol; guideline; prevention & control

Mesh：

Substances：

Year:  2014        PMID： 24577963      PMCID： PMC4007275          DOI： 10.1161/CIRCRESAHA.114.303333

Source DB:  PubMed          Journal:  Circ Res        ISSN： 0009-7330            Impact factor:   17.367


× No keyword cloud information.
  14 in total

Review 1.  Statin myopathy: a common dilemma not reflected in clinical trials.

Authors:  Genaro Fernandez; Erica S Spatz; Charles Jablecki; Paul S Phillips
Journal:  Cleve Clin J Med       Date:  2011-06       Impact factor: 2.321

2.  Needed: pragmatic clinical trials for statin-intolerant patients.

Authors:  Patricia Maningat; Jan L Breslow
Journal:  N Engl J Med       Date:  2011-11-15       Impact factor: 91.245

Review 3.  Primary prevention of cardiovascular diseases with statin therapy: a meta-analysis of randomized controlled trials.

Authors:  Paaladinesh Thavendiranathan; Akshay Bagai; M Alan Brookhart; Niteesh K Choudhry
Journal:  Arch Intern Med       Date:  2006-11-27

4.  Are lipid-lowering guidelines evidence-based?

Authors:  J Abramson; J M Wright
Journal:  Lancet       Date:  2007-01-20       Impact factor: 79.321

5.  2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.

Authors:  Neil J Stone; Jennifer G Robinson; Alice H Lichtenstein; C Noel Bairey Merz; Conrad B Blum; Robert H Eckel; Anne C Goldberg; David Gordon; Daniel Levy; Donald M Lloyd-Jones; Patrick McBride; J Sanford Schwartz; Susan T Shero; Sidney C Smith; Karol Watson; Peter W F Wilson
Journal:  J Am Coll Cardiol       Date:  2013-11-12       Impact factor: 24.094

Review 6.  Statins and all-cause mortality in high-risk primary prevention: a meta-analysis of 11 randomized controlled trials involving 65,229 participants.

Authors:  Kausik K Ray; Sreenivasa Rao Kondapally Seshasai; Sebhat Erqou; Peter Sever; J Wouter Jukema; Ian Ford; Naveed Sattar
Journal:  Arch Intern Med       Date:  2010-06-28

7.  Mild to moderate muscular symptoms with high-dosage statin therapy in hyperlipidemic patients--the PRIMO study.

Authors:  Eric Bruckert; Gilles Hayem; Sylvie Dejager; Caroline Yau; Bernard Bégaud
Journal:  Cardiovasc Drugs Ther       Date:  2005-12       Impact factor: 3.727

Review 8.  The benefits of statins in people without established cardiovascular disease but with cardiovascular risk factors: meta-analysis of randomised controlled trials.

Authors:  J J Brugts; T Yetgin; S E Hoeks; A M Gotto; J Shepherd; R G J Westendorp; A J M de Craen; R H Knopp; H Nakamura; P Ridker; R van Domburg; J W Deckers
Journal:  BMJ       Date:  2009-06-30

9.  Primary prevention of cardiovascular mortality and events with statin treatments: a network meta-analysis involving more than 65,000 patients.

Authors:  Edward J Mills; Beth Rachlis; Ping Wu; Philip J Devereaux; Paul Arora; Dan Perri
Journal:  J Am Coll Cardiol       Date:  2008-11-25       Impact factor: 24.094

10.  The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials.

Authors:  B Mihaylova; J Emberson; L Blackwell; A Keech; J Simes; E H Barnes; M Voysey; A Gray; R Collins; C Baigent
Journal:  Lancet       Date:  2012-05-17       Impact factor: 79.321
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.